Skip to main content
editorial
. 2025 Feb 12;5(1):e42. doi: 10.1017/ash.2024.495

Table 1.

Challenges with utilization of the AXR metric and tactics to optimize impact

Challenges Tactics
Creating metric meaning for clinicians
• A non-dichotomous metric that includes patients who “sometimes” should receive antibiotics
• Need to clearly communicate that metric is benchmarked by service line
• Report and monitor AXR at an organization and service line-level, but report more concrete metrics to clinicians (for example: URI, AAB, CWP)
• Report clinician AXR performance over time
Identifying optimal targets
• Not yet clear what the “ideal” rate is and may vary across different systems, service lines, and geographies
• Unclear how to benchmark across systems with variable patient acuity and heterogeneity
• Tracking over time will be limited as population case mix varies
• Set initial target at median, with subsequent stepwise decrease over time
• Benchmark to similar regional healthcare systems
Limitations of the metric
• Does not distinguish narrow- vs broad-spectrum antimicrobial use
• Does not capture if antibiotic was prescribed at appropriate dose or duration
• Does not include antibiotic use in non-respiratory conditions
• Report days of therapy per diagnosis as an additional rate measure
• Co-report rates of broad-spectrum antibiotic use or high-risk antimicrobial use
Incorporating AXR into the HEDIS® metric landscape
• AXR is the 4th antimicrobial stewardship-focused HEDIS® measure
• Institutional bandwidth to target all four may be limited
• Target the HEDIS® metric or other clinically impactful, associated stewardship metric with the largest room for improvement, as this will also impact AXR performance
Assessing Equitable Care
• AXR does not provide granular insight into why antibiotic prescription rates vary between patient groups
• Assess differential trends in AXR performance between groups following stewardship interventions
• Engage stakeholders to understand reasons for disparities

Legend: AXR = percentage of episodes for patients 3 months of age and older with a diagnosis of a respiratory condition that resulted in an antibiotic dispensing event, URI = avoidance of antibiotic prescribing for upper respiratory infection, AAB = avoidance of antibiotic prescribing for acute bronchitis/bronchiolitis, CWP = appropriate testing for group A streptococcus prior to antibiotic dispensing for pharyngitis, HEDIS® = Healthcare Effectiveness Data and Information Set